BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30895910)

  • 1. Feline Hypertrophic Cardiomyopathy: The Consequence of Cardiomyocyte-Initiated and Macrophage-Driven Remodeling Processes?
    Kitz S; Fonfara S; Hahn S; Hetzel U; Kipar A
    Vet Pathol; 2019 Jul; 56(4):565-575. PubMed ID: 30895910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial transcription of inflammatory and remodeling markers in cats with hypertrophic cardiomyopathy and systemic diseases associated with an inflammatory phenotype.
    Fonfara S; Kitz S; Monteith G; Hahn S; Kipar A
    Res Vet Sci; 2021 May; 136():484-494. PubMed ID: 33848803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of morphometry in feline hypertrophic cardiomyopathy.
    Kershaw O; Heblinski N; Lotz F; Dirsch O; Gruber AD
    J Comp Pathol; 2012 Jul; 147(1):73-83. PubMed ID: 22297077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial collagen deposition and inflammatory cell infiltration in cats with pre-clinical hypertrophic cardiomyopathy.
    Khor KH; Campbell FE; Owen H; Shiels IA; Mills PC
    Vet J; 2015 Feb; 203(2):161-8. PubMed ID: 25573453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of end-stage remodeling in a family of cats with hypertrophic cardiomyopathy.
    Cesta MF; Baty CJ; Keene BW; Smoak IW; Malarkey DE
    Vet Pathol; 2005 Jul; 42(4):458-67. PubMed ID: 16006605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural myocardial changes in seven cats with spontaneous hypertrophic cardiomyopathy.
    Christiansen LB; Prats C; Hyttel P; Koch J
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S220-32. PubMed ID: 26776581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial leptin transcription in feline hypertrophic cardiomyopathy.
    Fonfara S; Kitz S; Hetzel U; Kipar A
    Res Vet Sci; 2017 Jun; 112():105-108. PubMed ID: 28213270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy in man and cats.
    Maron BJ; Fox PR
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S6-9. PubMed ID: 26776595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline hypertrophic cardiomyopathy: reduced microvascular density and involvement of CD34+ interstitial cells.
    Rodríguez JMM; Fonfara S; Hetzel U; Kipar A
    Vet Pathol; 2022 Mar; 59(2):269-283. PubMed ID: 34955067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine Dilated Cardiomyopathy: Diffuse Remodeling, Focal Lesions, and the Involvement of Macrophages and New Vessel Formation.
    Gasparini S; Fonfara S; Kitz S; Hetzel U; Kipar A
    Vet Pathol; 2020 May; 57(3):397-408. PubMed ID: 32125251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomopathological staging of feline hypertrophic cardiomyopathy through quantitative evaluation based on morphometric and histopathological data.
    Biasato I; Francescone L; La Rosa G; Tursi M
    Res Vet Sci; 2015 Oct; 102():136-41. PubMed ID: 26412533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feline hypertrophic cardiomyopathy: gross anatomic and quantitative histologic features.
    Liu SK; Maron BJ; Tilley LP
    Am J Pathol; 1981 Mar; 102(3):388-95. PubMed ID: 7193978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of the renin-angiotensin system in cats with hypertrophic cardiomyopathy.
    Taugner FM
    J Comp Pathol; 2001; 125(2-3):122-9. PubMed ID: 11578127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic alterations in hypertrophic and congestive cardiomyopathy of cats.
    Van Vleet JF; Ferrans VJ; Weirich WE
    Am J Vet Res; 1980 Dec; 41(12):2037-48. PubMed ID: 7194009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy.
    Biondo AW; Ehrhart EJ; Sisson DD; Bulmer BJ; De Morais HS; Solter PF
    Vet Pathol; 2003 Sep; 40(5):501-6. PubMed ID: 12949406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cardiac macroscopic and microscopic study in cats with hyperthyroidism vs. cats with hypertrophic cardiomyopathy.
    Janus I; Noszczyk-Nowak A; Bubak J; Tursi M; Vercelli C; Nowak M
    Vet Q; 2023 Dec; 43(1):1-11. PubMed ID: 37427551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro-computed tomography (micro-CT) for the assessment of myocardial disarray, fibrosis and ventricular mass in a feline model of hypertrophic cardiomyopathy.
    Novo Matos J; Garcia-Canadilla P; Simcock IC; Hutchinson JC; Dobromylskyj M; Guy A; Arthurs OJ; Cook AC; Luis Fuentes V
    Sci Rep; 2020 Nov; 10(1):20169. PubMed ID: 33214588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An insight of novel pharmacological therapies in hypertrophic cardiomyopathy.
    Orenes-Piñero E; Hernández-Romero D; Jover E; de la Morena G; Valdés M; Marín F
    Med Chem; 2011 Jul; 7(4):275-85. PubMed ID: 21568880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular involvement in feline hypertrophic cardiomyopathy.
    Schober KE; Savino SI; Yildiz V
    J Vet Cardiol; 2016 Dec; 18(4):297-309. PubMed ID: 27667689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic Assessment of Right Ventricular Size and Function in Cats With Hypertrophic Cardiomyopathy.
    Visser LC; Sloan CQ; Stern JA
    J Vet Intern Med; 2017 May; 31(3):668-677. PubMed ID: 28295648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.